City Therapeutics, Inc. (CTY)

NASDAQ

$20.60

$-0.18

(-0.86%)

Regular Market

City Therapeutics, Inc. (CTY) Live Price Chart

Last updated: ⁦2026-10-21 16:01:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

City Therapeutics, Inc. (CTY) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $20.60, with a market capitalization of $1.08B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $19.80 to $23.88. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$1.08B
Open	$20.78
Day's High	$25.97
Day's Low	$11.03
Previous Close	$20.83
Volume	133.68K
Average Volume	780.65K
P/E Ratio	--
52-Week High	$23.88
52-Week Low	$19.80
Dividend Yield	--
Earnings Date	--

City Therapeutics, Inc. (CTY) Stock Price Today

City Therapeutics, Inc. (CTY) is currently trading at $20.60 as of 2026-10-21 15:59:00, down 1.10% ($0.23) from the previous close of $20.83

During today's regular trading session, CTY has traded between $11.03 and $25.97, with a trading volume of 133.68K shares. The current price is near the middle of today's range.

City Therapeutics, Inc. (CTY) 7-Day Stock Price Change

Over the past seven days, City Therapeutics, Inc. (CTY) moved from $22.40 to $20.60, representing a decline of 8.04% ($1.80).

The stock traded between $19.80 and $23.88 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 780.65 thousand shares, -- versus the previous seven-day period, indicating -- trading activity.

CTY 52-Week Price Position

Position in Range: 19.6%

52W Low$19.80

52W High$23.88

CTY is currently trading at $20.60, placing it 19.6% of the way from its 52-week low of $19.80 to its 52-week high of $23.88. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is City Therapeutics, Inc. (CTY)?

City Therapeutics Inc is a clinical-stage biotechnology company developing the next generation of RNA interference (RNAi) therapeutics designed to silence the expression of disease-relevant proteins. Its current pipeline is focused on indications with unmet medical need, including thromboembolic diseases, Stargardt disease type 1 (Stargardt disease), and anemia of chronic disease.

City Therapeutics, Inc. Information

Exchange	NASDAQ
Company Website	https://www.citytx.com

How to Buy City Therapeutics, Inc. (CTY) Stock on MEXC

Eligible investors can buy real shares of City Therapeutics, Inc. (CTY) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for CTY and Place Your Order

Open the RealStocks trading page and search for CTY. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is City Therapeutics, Inc. (CTY) stock price today?

City Therapeutics, Inc. (CTY) is currently trading at $ 20.60, down 1.10% ($0.23) from the previous close of $ 20.83. Intraday prices update in real time during regular trading hours.

2.Is CTY stock going up or down today?

As of 2026-10-21 15:59:00, CTY is trading at $ 20.60, down 1.10% ($0.23) from its previous close of $ 20.83. The stock has traded between $ 11.03 and $ 25.97 during today’s regular session. Past price movements do not guarantee future results.

3.What is CTY pre-market price?

As of 2026-10-21 15:59:00, CTY is trading at $ 20.97 in pre-market trading, up 0.67% ($0.14) from the previous close of $ 20.83. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is CTY after-hours price?

As of 2026-10-21 15:59:00, CTY is trading at $ 21.32 in after-hours trading, up 2.35% ($0.49) from the regular-session close of $ 20.83. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is CTY stock trading now?

CTY trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does CTY sit relative to its 52-week high and low?

Over the past 52 weeks, CTY has traded between a low of $ 19.80 and a high of $ 23.88. At $ 20.60, the stock is positioned 19.6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is City Therapeutics, Inc. in?

City Therapeutics, Inc. (CTY) operates in the -- sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is City Therapeutics, Inc.'s market capitalization and where is it listed?

City Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 1.08B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is CTY valued in terms of P/E ratio and EPS?

CTY trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does City Therapeutics, Inc. pay a dividend?

City Therapeutics, Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.